Lotus Pharmaceutical Co (TPE:1795) says its Singapore-based subsidiary has agreed to sell a 100% stake in Lotus Pharma Bulgaria for $99 million, according to a Thursday filing to the Taiwan stock exchange.
Under the pact, the company will sell 537,711 shares at $184.11 apiece to Lotus Investment Holding SARL.
The move is aimed at adjusting the investment structure of the group, the company said.